Literature DB >> 25129176

Microribonucleic acids and vascular restenosis.

Zhi-Xing Fan1, Jian Yang.   

Abstract

Microribonucleic acids (miRNAs) are small non-coding RNAs, which control diverse cellular functions by either promoting degradation or inhibiting target messenger RNA translation. An aberrant expression profile of miRNAs has been linked to human diseases, including cardiovascular dysfunction. This review summarizes the latest insights in the identification of vascular-specific miRNAs and the underlying mechanisms for their roles in vascular restenosis mainly by influencing the proliferation and migration of vascular smooth muscle cell. Here, we discuss miRNA-based drug and gene therapy in vascular restenosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25129176

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  5 in total

Review 1.  Non-coding RNAs modulate autophagy in myocardial ischemia-reperfusion injury: a systematic review.

Authors:  Fuwen Huang; Jingting Mai; Jingwei Chen; Yinying He; Xiaojun Chen
Journal:  J Cardiothorac Surg       Date:  2021-05-22       Impact factor: 1.637

Review 2.  The role of microRNAs in regulating myocardial ischemia reperfusion injury.

Authors:  Zhi-Xing Fan; Jian Yang
Journal:  Saudi Med J       Date:  2015-07       Impact factor: 1.484

3.  MicroRNA-24 Attenuates Neointimal Hyperplasia in the Diabetic Rat Carotid Artery Injury Model by Inhibiting Wnt4 Signaling Pathway.

Authors:  Jian Yang; Zhixing Fan; Jun Yang; Jiawang Ding; Chaojun Yang; Lihua Chen
Journal:  Int J Mol Sci       Date:  2016-05-24       Impact factor: 5.923

4.  microRNA-22 attenuates myocardial ischemia-reperfusion injury via an anti-inflammatory mechanism in rats.

Authors:  Jian Yang; Zhixing Fan; Jun Yang; Jiawang Ding; Chaojun Yang; Lihua Chen
Journal:  Exp Ther Med       Date:  2016-10-04       Impact factor: 2.447

5.  MicroRNA‑24 attenuates diabetic vascular remodeling by suppressing the NLRP3/caspase‑1/IL‑1β signaling pathway.

Authors:  Zhixing Fan; Jian Yang; Chaojun Yang; Jing Zhang; Wanying Cai; Congxin Huang
Journal:  Int J Mol Med       Date:  2020-03-09       Impact factor: 4.101

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.